Related Experiment Videos
[Anesthesia for a patient with xeroderma pigmentosum]
Yoshiki Masuda1, Hitoshi Imaizumi, Mioko Okanuma
1Department of Traumatology and Critical Care Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8543.
Masui. the Japanese Journal of Anesthesiology
|March 14, 2002
Summary
Anesthetic management for xeroderma pigmentosum (XP) patients requires caution. Volatile anesthetics may exacerbate XP symptoms due to nucleotide excision repair (NER) defects, suggesting alternative anesthetic approaches.
Area of Science:
- Anesthesiology
- Genetics
- Dermatology
Background:
- Xeroderma pigmentosum (XP) is a rare genetic disorder characterized by extreme sun sensitivity, high skin cancer rates, and neurological issues.
- XP involves defects in DNA repair mechanisms, particularly nucleotide excision repair (NER).
- Previous research suggests volatile anesthetics can impair NER in XP cells.
Observation:
- A case study details the anesthetic management of a 17-year-old female with XP undergoing tracheostomy.
- The patient experienced progressive recurrent nerve palsy, necessitating the surgical procedure.
- General anesthesia was successfully administered using propofol and fentanyl without immediate complications.
Findings:
- The successful use of propofol and fentanyl indicates that non-volatile anesthetic agents may be a safer option for XP patients.
- The study highlights the potential risks associated with volatile anesthetics in individuals with XP.
- This case underscores the importance of considering the specific DNA repair defects in XP when selecting anesthetic agents.
Implications:
- Anesthesiologists should consider avoiding volatile anesthetics in XP patients to prevent potential worsening of neurological symptoms.
- Further research is needed to establish definitive anesthetic guidelines for patients with xeroderma pigmentosum.
- This case contributes to the understanding of safe anesthetic practices for rare genetic disorders affecting DNA repair.